# Marillac Clinic, Inc.

Health Center, CO
Page: https://astrelis.co/providers/health_center/061968  
This twin: https://astrelis.co/providers/health_center/061968.md  
CMS Certification Number (CCN): 061968  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 16,426. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -58.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 7. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 19.6%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $13.8M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +4.1%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Marillac Clinic Inc. dba PrimeHealth, CO

Match to this profile: identifier verified: the EIN the dataset carries for this CCN agrees with the filed EIN (method: exact name and state, narrowed by address (FACLAND tier 1+3)).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000421480
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000367485
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000039268

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 3,292,299 [derived, p.6] | 21,158,380 [derived, p.6] | 2,930,621 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 1,821,917 [derived, p.6] | 1,776,158 [derived, p.6] | 1,351,541 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 881,636 [derived, p.6] | 599,985 [derived, p.6] | 336,956 [derived, p.6] |
| other current assets (Statement of financial position) | 619,443 [derived, p.6] | 402,283 [derived, p.6] | 6,140,035 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 6,615,295 [extracted, p.6] | 23,936,806 [extracted, p.6] | 10,759,153 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 23,723,846 [derived, p.6] | 10,055,829 [derived, p.6] | 1,181,342 [derived, p.6] |
| other long-term assets (Statement of financial position) | 15,725,205 [derived, p.6] | 15,920,006 [derived, p.6] | 608,435 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 46,064,346 [extracted, p.6] | 49,912,641 [extracted, p.6] | 12,548,930 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 2,295,520 [derived, p.6] | 4,866,056 [derived, p.6] | 1,284,263 [derived, p.6] |
| deferred revenue (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | 214,105 [derived, p.6] | 186,399 [derived, p.6] | 289,228 [derived, p.6] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 2,509,625 [extracted, p.6] | 5,052,455 [extracted, p.6] | 1,573,491 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 30,405,789 [derived, p.6] | 32,405,901 [derived, p.6] | 285,805 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 32,915,414 [extracted, p.6] | 37,458,356 [extracted, p.6] | 1,859,296 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 12,621,630 [derived, p.6] | 11,912,940 [derived, p.6] | 9,931,217 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | 527,302 [derived, p.6] | 541,345 [derived, p.6] | 758,417 [derived, p.6] |
| TOTAL NET ASSETS (Statement of financial position) | 13,148,932 [extracted, p.6] | 12,454,285 [extracted, p.6] | 10,689,634 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 12,848,775 [derived, p.7] | 12,153,076 [derived, p.7] | 7,848,244 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | 1,917,416 [derived, p.7] | 2,675,877 [derived, p.7] | 1,754,439 [derived, p.7] |
| other grants and contracts (Statement of activities) | 3,111,635 [derived, p.7] | 2,370,891 [derived, p.7] | 2,162,691 [derived, p.7] |
| contributions (Statement of activities) | 96,909 [derived, p.7] | 919,903 [derived, p.7] | 51,467 [derived, p.7] |
| other revenue (Statement of activities) | 2,602,127 [derived, p.7] | 2,028,871 [derived, p.7] | 1,051,680 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 20,576,862 [extracted, p.7] | 20,148,618 [extracted, p.7] | 12,868,521 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 12,460,641 [derived, p.7] | 10,914,686 [derived, p.7] | 8,119,969 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | 3,599,623 [derived, p.7] | 2,123,131 [derived, p.7] | 1,281,563 [derived, p.7] |
| purchased and professional services (Statement of activities) | 3,555,534 [derived, p.7] | 3,477,858 [derived, p.7] | 2,824,893 [derived, p.7] |
| occupancy (Statement of activities) | 625,881 [derived, p.7] | 647,245 [derived, p.7] | 569,772 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 703,448 [derived, p.7] | 291,867 [derived, p.7] | 217,020 [derived, p.7] |
| interest (Statement of activities) | 428,346 [derived, p.7] | 20,503 [derived, p.7] | absent (not printed, or not read) |
| other expenses (Statement of activities) | 869,771 [derived, p.7] | 828,144 [derived, p.7] | 684,690 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 22,243,244 [extracted, p.7] | 18,303,434 [extracted, p.7] | 13,697,907 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | -1,666,382 [extracted, p.7] | 1,845,184 [extracted, p.7] | -829,386 [extracted, p.7] |
| non-operating and other changes (Statement of activities) | 2,361,029 [derived, p.8] | -80,533 [derived, p.8] | 599,564 [derived, p.8] |
| CHANGE IN NET ASSETS (Statement of activities) | 694,647 [extracted, p.8] | 1,764,651 [extracted, p.8] | -229,822 [extracted, p.8] |
| net assets, beginning (Statement of activities) | 12,454,285 [extracted, p.8] | 10,689,634 [extracted, p.8] | 10,919,456 [extracted, p.8] |
| net assets, end (Statement of activities) | 13,148,932 [extracted, p.8] | 12,454,285 [extracted, p.8] | 10,689,634 [extracted, p.8] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 56 days [plausible] | 430 days [plausible] | 79 days [plausible] |
| Current ratio | 2.64x [plausible] | 4.74x [plausible] | 6.84x [plausible] |
| Operating margin | -8.1% [plausible] | 9.2% [plausible] | -6.4% [plausible] |
| Total margin | 3.4% [plausible] | 8.8% [plausible] | -1.8% [plausible] |
| Patient revenue share | 62.4% [plausible] | 60.3% [plausible] | 61.0% [plausible] |
| Grant dependency | 24.4% [plausible] | 25.0% [plausible] | 30.4% [plausible] |
| Salaries share | 56.0% [plausible] | 59.6% [plausible] | 59.3% [plausible] |
| Days in patient receivables | 52 days [plausible] | 53 days [plausible] | 63 days [plausible] |
| Debt to net assets | 2.33x [plausible] | 2.62x [plausible] | 0.05x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Marillac Clinic Inc. dba PrimeHealth; FAC-11 template snapshot, SRC-FAC-001).

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Marillac Clinic, Inc.", https://astrelis.co/providers/health_center/061968, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.